Jane Street Group LLC purchased a new position in Applied DNA Sciences, Inc. (NASDAQ:APDN – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 73,396 shares of the technology company’s stock, valued at approximately $48,000.
Applied DNA Sciences Stock Up 7.9 %
APDN stock opened at $0.20 on Thursday. Applied DNA Sciences, Inc. has a twelve month low of $0.12 and a twelve month high of $14.40. The stock has a market capitalization of $10.30 million, a price-to-earnings ratio of -0.02 and a beta of 0.40. The firm’s fifty day simple moving average is $0.19 and its two-hundred day simple moving average is $0.56.
Applied DNA Sciences (NASDAQ:APDN – Get Free Report) last issued its earnings results on Tuesday, December 17th. The technology company reported ($0.32) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.01. Applied DNA Sciences had a negative net margin of 214.42% and a negative return on equity of 138.41%. As a group, equities research analysts expect that Applied DNA Sciences, Inc. will post -1.8 EPS for the current year.
Applied DNA Sciences Company Profile
Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.
Recommended Stories
- Five stocks we like better than Applied DNA Sciences
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- How Do Stock Buybacks Affect Shareholders?
- EV Stocks and How to Profit from Them
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Want to see what other hedge funds are holding APDN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Applied DNA Sciences, Inc. (NASDAQ:APDN – Free Report).
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.